Cash on Hand for Elevance Health (ELV)
According to Elevance Health's latest reported financial statements, the company's latest reported cash and short-term investments is $35.56B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$35.56B
YoY change
+14.5%
5Y CAGR
+10.6%
Peak year (2025)
$9.49B
Latest annual
$9.49B
Cash on Hand history chart for Elevance Health (ELV) from 1998 to 2025
Cash on Hand history table for Elevance Health (ELV) from 1998 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $9.49B | +14.5% | ||
| 2024 | $8.29B | +27.0% | ||
| 2023 | $6.53B | -11.7% | ||
| 2022 | $7.39B | +51.4% | ||
| 2021 | $4.88B | -15.0% | ||
| 2020 | $5.74B | +16.3% | ||
| 2019 | $4.94B | +25.5% | ||
| 2018 | $3.93B | +9.0% | ||
| 2017 | $3.61B | -11.4% | ||
| 2016 | $4.08B | +92.8% | ||
| 2015 | $2.11B | -1.8% | ||
| 2014 | $2.15B | +36.0% | ||
| 2013 | $1.58B | -36.1% | ||
| 2012 | $2.48B | +12.4% | ||
| 2011 | $2.20B | +23.1% | ||
| 2010 | $1.79B | -62.9% | ||
| 2009 | $4.82B | +120.5% | ||
| 2008 | $2.18B | -21.1% | ||
| 2007 | $2.77B | +6.4% | ||
| 2006 | $2.60B | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | -100.0% | ||
| 2003 | $7.38B | +11.1% | ||
| 2002 | $6.64B | +48.3% | ||
| 2001 | $4.48B | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — |
Cash on Hand values are taken from Elevance Health's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual cash and short-term investments for Elevance Health (ELV) came in at $9.49B – grew 14.5% year-over-year.
Over 2020–2025 (5 years), Elevance Health cash and short-term investments expanded at a +10.6% compound annual rate, sustaining 2 straight years of year-over-year growth.
2025 marks the peak cash and short-term investments at $9.49B, with the historical low of $0 recorded in 1998.
Among 8 Healthcare peers, Elevance Health (ELV) ranks 5th; the peer median for cash and short-term investments is $11.85B.
Elevance Health Cash on Hand by Year
Elevance Health Cash on Hand 2025: $9.49B
Elevance Health cash and short-term investments in 2025 was $9.49B, grew 14.5% from 2024. This figure represents the highest annual value in the available history.
Elevance Health Cash on Hand 2024: $8.29B
Elevance Health cash and short-term investments in 2024 was $8.29B, grew 27.0% from 2023.
Elevance Health Cash on Hand 2023: $6.53B
Elevance Health cash and short-term investments in 2023 was $6.53B, declined 11.7% below 2022.
Elevance Health Cash on Hand 2022: $7.39B
Elevance Health cash and short-term investments in 2022 was $7.39B, surged 51.4% from 2021.
Elevance Health Cash on Hand 2021: $4.88B
Elevance Health cash and short-term investments in 2021 was $4.88B.
See more financial history for Elevance Health (ELV).
Sector peers — Cash on Hand
Companies in the same sector as Elevance Health, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Elevance Health's cash and short-term investments?
- Latest reported cash and short-term investments for Elevance Health (ELV) is $35.56B (period ending March 31, 2026).
How has Elevance Health cash and short-term investments changed year-over-year?
- Elevance Health (ELV) cash and short-term investments changed +14.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Elevance Health cash and short-term investments?
- Elevance Health (ELV) cash and short-term investments compound annual growth rate is +10.6% over the most recent 5 years available.
When did Elevance Health cash and short-term investments hit its highest annual value?
- Elevance Health cash and short-term investments reached its highest annual value of $9.49B in 2025.
What was Elevance Health cash and short-term investments in 2024?
- Elevance Health (ELV) cash and short-term investments in 2024 was $8.29B.
What was Elevance Health cash and short-term investments in 2025?
- Elevance Health (ELV) cash and short-term investments in 2025 was $9.49B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ELV Overview
Company profile, financial tools, and key metrics
ELV Revenue Counter
Earns $6,355 every second. See per minute, hour, and day.
ELV Earnings Counter
Earns $166.25 per second net profit. See per minute, hour, and day.
ELV Economic Scale
Exceeds Ukraine's GDP. Compare with world economies.
ELV What If Invested
What if you had invested $1,000? See historical returns from any date.
ELV How It Makes Money
Discover visual breakdown of $200.41B in revenue — where it comes from and where it goes.
ELV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ELV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ELV Daily Price Character
Steady · 51.8% historical win rate (green days). Streaks & record days.
ELV Buybacks
4.41% TTM buyback yield. Shareholder yield & SBC comparison.
ELV Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.
ELV Dividend Profile
Yield: 1.82%. Safety: 7/8. See full history.
ELV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ELV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.